D.E. Shaw & Co’s Tabula Rasa HealthCare, Inc. Common Stock TRHC Stock Holding History

D.E. Shaw & Co’s Portfolio TRHC Stock Details TRHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,108,108	Closed	-$2.85M	–	5661
2022 Q2	$2.85M	Buy	1,108,108 +215,152	+24%	+$807K	﹤0.01%	2757
2022 Q1	$5.14M	Buy	892,956 +742,642	+494%	+$6.67M	﹤0.01%	2275
2021 Q4	$2.25M	Buy	150,314 +23,394	+18%	+$426K	﹤0.01%	3248
2021 Q3	$3.33M	Buy	126,920 +86,429	+213%	+$3.18M	﹤0.01%	2518
2021 Q2	$2.02M	Buy	40,491 +31,954	+374%	+$1.43M	﹤0.01%	2929
2021 Q1	$393K	Buy	+8,537	New	+$407K	﹤0.01%	3610
2020 Q2	–	Sell	-3,981	Closed	-$208K	–	4310
2020 Q1	$208K	Buy	+3,981	New	+$216K	﹤0.01%	3630

Other funds holding TRHC

ICM

Indaba Capital Management San Francisco, California $33.8M AUM 33.83% 1-Year Est. Return

Repertoire Partners New York $143M AUM 28.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Cannell & Spears New York $5.1B AUM 31.77% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

D.E. Shaw & Co's TRHC Position: Q3 2022 in Review

D.E. Shaw & Co sold out of Tabula Rasa HealthCare, Inc. Common Stock (TRHC) in Q3 2022, closing a stake of 1,108,108 shares — an estimated $2.85M sold.

D.E. Shaw & Co first reported a position in TRHC in Q1 2020 and held it in 7 quarters. The position peaked at $5.14M in Q1 2022. 80 funds tracked by Wall St. Rank hold TRHC as of Q3 2022.

D.E. Shaw & Co reported no remaining Tabula Rasa HealthCare, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
D.E. Shaw & Co sold 1,108,108 Tabula Rasa HealthCare, Inc. Common Stock shares in Q3 2022, an estimated $2.85M.
D.E. Shaw & Co first reported a position in Tabula Rasa HealthCare, Inc. Common Stock in Q1 2020 and held it in 7 quarters.
D.E. Shaw & Co's Tabula Rasa HealthCare, Inc. Common Stock position peaked at $5.14M in Q1 2022.
80 funds tracked by Wall St. Rank held Tabula Rasa HealthCare, Inc. Common Stock as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.